The prevalence and characteristics of MCCB cognitive impairment in unmedicated patients with bipolar II depression and major depressive disorder

Autor: Shunkai, Lai, Shuming, Zhong, Ying, Wang, Yiliang, Zhang, Ying, Xue, Hui, Zhao, Hanglin, Ran, Shuya, Yan, Yange, Luo, Jiali, He, Yunxia, Zhu, Sihui, Lv, Zijing, Song, Haofei, Miao, Yilei, Hu, Xiaosi, Huang, Xiaodan, Lu, Jiansong, Zhou, Yanbin, Jia
Rok vydání: 2022
Předmět:
Zdroj: Journal of Affective Disorders. 310:369-376
ISSN: 0165-0327
Popis: Cognitive impairment has been acknowledged as a core clinical manifestation of bipolar disorder (BD) as well as major depressive disorder (MDD). Determining the prevalence and characteristics of cognitive impairment is important for clinical interventions. This study investigated the prevalence and characteristics of cognitive impairment based on the Measurement and Treatment Research to Improve Cognition Schizophrenia Consensus Cognitive Battery (MCCB) in both BD and MDD.One hundred and forty-nine BD II depression, 147 MDD, and 124 demographically matched healthy controls (HC) underwent MCCB cognitive assessment. The prevalence of MCCB cognitive impairment and group difference comparisons were performed. Additionally, association analysis was performed to investigate the relationship between cognitive performance and clinical variables.Compared to the HC group, both BD II depression and MDD groups had a significantly reduced performance for all MCCB cognitive domains (all p 0.05). The numerical scores for visual learning were lower in the BD II depression group compared to the MDD group. 32.89% of the BD II depression patients had clinically significant impairment (1.5 SD below the normal mean) in two or more MCCB domains compared to 23.13% for MDD patients.A high percent of patients in the BD II depression and MDD group exhibited MCCB cognitive impairments with clinical significance. Cognitive impairments were more common in BD II depression patients compared to MDD patients, particularly for visual learning. These findings suggest that clinicians should be aware of the severe cognitive impairment in mood disorders and establish effective cognitive screening and intervention strategies.
Databáze: OpenAIRE